Anna Ehinger
21 – 30 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Molecular analyses of triple-negative breast cancer in the young and elderly
- Contribution to journal › Article
-
Mark
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
- Contribution to journal › Article
-
Mark
Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions
- Contribution to journal › Article
-
Mark
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
- Contribution to journal › Scientific review
- 2020
-
Mark
Abstract CT074: Pre-existing ESR1 mutations in early-stage primary breast cancer predict failure of endocrine therapy and poor survival
- Contribution to journal › Published meeting abstract
-
Mark
Kvalitetsbilaga för bröstpatologi (KVAST-bilaga) : Tillhörande Nationellt vårdprogram för bröstcancer
(2020)
- Other contribution › Miscellaneous
-
Mark
Sex differences in oncogenic mutational processes
- Contribution to journal › Article
-
Mark
The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome
- Contribution to journal › Article
-
Mark
Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P1-18-10: Preoperative treatment of HER2-positive breast cancer in South Sweden. A retrospective, comprehensive survey of neo-adjuvant treated HER2-positve breast cancer in the SCAN-B project 2010-2017
(2020) San Antonio Breast Cancer Symposium, 2019 In Cancer research. Supplement 80(Issue 4 Supplement). p.1-18
- Contribution to journal › Published meeting abstract
